Cilostazol-d6

• Description:

  Cilostazol-d6 (OPC 13013-d6) is deuterium labeled Cilostazol. Cilostazol (OPC 13013) is a potent and selective inhibitor of phosphodiesterase (PDE) 3A, the isoform of PDE 3 in the cardiovascular system, with an IC50 of 0.2 μM[1][2].

• Product Name Alternative:

  OPC 13013-d6

• UNSPSC:

  12352005

• Target:

  Isotope-Labeled Compounds

• Related Pathways:

  Others

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cardiovascular Disease; Cancer

• Smiles:

  O=C1NC2=CC=C (OCCCCC3=NN=NN3C4CC ([2H]) (C ([2H]) (C ([2H]) (C4) [2H]) [2H]) [2H]) C=C2CC1

• Molecular Formula:

  C20H21D6N5O2

• Molecular Weight:

  375.50

• References & Citations:

  [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Isotope-Labeled Compounds

• Clinical Information:

  No Development Reported

• CAS Number:

  1246641-05-3